GSA CAPITAL PARTNERS LLP - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 64 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$443,000
-43.9%
372,208
+53.7%
0.06%
-40.4%
Q4 2021$789,000
+60.0%
242,132
+119.4%
0.10%
+98.0%
Q3 2021$493,000
-35.8%
110,337
-21.7%
0.05%
-41.9%
Q2 2021$768,000
+58.4%
140,991
+117.5%
0.09%
+7.5%
Q1 2021$485,000
+152.6%
64,830
+133.6%
0.08%
+263.6%
Q4 2019$192,000
+3.2%
27,756
+38.3%
0.02%
+4.8%
Q2 2019$186,000
-47.2%
20,070
-48.0%
0.02%
-41.7%
Q1 2019$352,000
+20.1%
38,563
-26.7%
0.04%
+5.9%
Q4 2018$293,000
-69.8%
52,577
-35.4%
0.03%
-37.0%
Q3 2018$969,000
+142.2%
81,377
+107.7%
0.05%
+170.0%
Q2 2018$400,000
-71.7%
39,177
-64.0%
0.02%
-73.3%
Q1 2018$1,414,000
+489.2%
108,900
+568.1%
0.08%
+368.8%
Q3 2017$240,00016,3000.02%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 3,439,895$18,747,0004.66%
Bain Capital Life Sciences Investors, LLC 5,785,036$31,528,0002.07%
Omega Fund Management, LLC 2,274,831$12,398,0001.40%
Altium Capital Management LP 1,076,942$5,869,0001.36%
Samsara BioCapital, LLC 2,189,199$10,599,0001.31%
Sio Capital Management, LLC 800,000$4,360,0001.08%
Flagship Pioneering Inc. 2,938,494$16,015,0000.20%
EcoR1 Capital, LLC 1,000,000$5,450,0000.20%
Artal Group S.A. 1,700,000$9,265,0000.19%
ACT CAPITAL MANAGEMENT, LLC 52,500$287,0000.15%
View complete list of SYROS PHARMACEUTICALS INC shareholders